The Postpartum Depression Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
What are the Historical Growth Trends in the Postpartum Depression Market?
The Postpartum Depression Global Market was worth $12.15 billion in 2024 and it is predicted to reach $16.09 billion in 2025, growing at a compound annual growth rate (CAGR) of 32.4%.
What are the 2025 Market Projections: Forecasted Size & Growth Rate for the Postpartum Depression Industry?
The Postpartum Depression Global Market Report 2025 forecasts that the market will expand to $49.4 billion in 2029, with a compound annual growth rate (CAGR) of 32.4%.
Download Your Free Sample of the 2025 Postpartum Depression Market Report and Uncover Key Trends Now!
What are the Key Growth Drivers Fueling the Postpartum Depression Market?
The key drivers in the postpartum depression market are:
• Expansion of telehealth services
• Advancements in pharmacological treatments
• Implementation of maternal mental health legislation
• Expansion of the mental health workforce
Global Market Segmentation: Identifying Major Postpartum Depression Industry Segments
The postpartum depression market covered in this report is segmented –
1) By Types: Postpartum Blues, Postpartum Anxiety, Postpartum Obsessive Compulsive Disorder, Postpartum Panic Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Psychosis, Other Types
2) By Treatment: Psychotherapy, Medication, Supplements, Other Treatments
3) By Route of Administration: Oral, Parenteral, Other Route Of Administration
4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels
5) End-Users: Hospitals, Specialty Clinics, Homecare, Other End-Users
Pre-order the 2025 Postpartum Depression Global Market Report for Fast Delivery & Comprehensive Insights!
What are the Emerging Trends Shaping the Future of the Postpartum Depression Market?
The key trends in the postpartum depression market are:
• The integration of healthcare services is an emerging trend in the postpartum depression market.
• The deployment of peer support programs is influencing future market developments.
• The use of perinatal mental health applications is a significantly rising trend.
• The application of mental health screening tools is another key upcoming trend in this market.
Who Are the Top Competitors & Leading Players in the Postpartum Depression Market?
Major companies in the postpartum depression market are:
• Pfizer Inc.
• Johnson & Johnson
• Roche Holding AG
• Merck & Co.
• AbbVie Inc.
• Novartis AG
• Sanofi SA
• Bristol Myers Squibb Co.
• AstraZeneca PLC
• GlaxoSmithKline LLC
• Takeda Pharmaceutical Company
• Eli Lilly and Company
• Gilead Sciences Inc.
• Amgen Inc.
• Moderna Inc.
• BioNTech SE
• Viatris Inc.
• Northwell Health
• Teva Pharmaceutical Industries Ltd.
• Regeneron Pharmaceuticals Inc.
• Biogen Inc.
• Vertex Pharmaceuticals Inc.
• Sun Pharmaceutical Industries Ltd.
• Lupin Pharmaceuticals
• Mallinckrodt Pharmaceuticals PLC
• Sage Therapeutics Inc.
Regional Dominance: Which Area Leads the Global Postpartum Depression Market?
North America was the largest region in the postpartum depression market in 2024
